Xinlay (atrasentan) is an investigational, oral, once-daily, non-hormonal, non-chemotherapy, agent that belongs to a class of compounds known as selective endothelin-A receptor antagonists developed by Abbott Laboratories. These agents are being investigated because of their potential to block endothelin activity that is involved in the spread of cancer cells.
Xinlay has fast track review status at the United States Food and Drug Administration (FDA). FDA agreed to file Abbott's New D...
| Currently you cannot purchase Xnlay as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Xnlay |
| Xnlay Availability Subscription Form |
|
| |
| Note: We will email you when Xnlay is available for sale online or in pharmacy in your country. |
|
|
|
|